Cipla plans to approve a drug Q-TIB in South Africa for the treatment of tuberculosis in HIV-positive people
The pharmaceutical company Cipla announced its intention to approve in South Africa a drug Q-TIB, intended for the treatment of co-infection of tuberculosis in people living with HIV. According to the company, Q-TIB is a combination of 3-in-1: co-trimoxazole, isoniazid and ...